Valuation: STAAR Surgical Company

Market Cap 1.03B 902M 852M 777M 1.45B 98.57B 1.46B 10.2B 3.95B 50.36B 3.86B 3.78B 162B P/E 2026 *
72.1x
P/E 2027 * 38x
Enterprise Value 833M 731M 691M 629M 1.18B 79.86B 1.19B 8.26B 3.2B 40.8B 3.13B 3.06B 131B EV / Sales 2026 *
2.49x
EV / Sales 2027 * 2.18x
Free-Float
98.41%
Yield 2026 *
-
Yield 2027 * -
1 day+7.49%
1 week-1.49%
Current month-9.21%
1 month-11.52%
3 months-34.28%
6 months+6.88%
Current year-11.17%
1 week 19.05
Extreme 19.05
21.03
1 month 19.05
Extreme 19.05
24.36
Current year 15.58
Extreme 15.585
35.87
1 year 15.58
Extreme 15.585
35.87
3 years 13.5
Extreme 13.5
52.68
5 years 13.5
Extreme 13.5
141.64
10 years 7.46
Extreme 7.455
163.08
Manager TitleAgeSince
Chief Executive Officer 77 2000-12-27
Chief Executive Officer 50 2026-01-31
Director of Finance/CFO 68 2017-04-27
Director TitleAgeSince
Director/Board Member 50 2026-08-03
Director/Board Member 43 2023-11-30
Director/Board Member 55 2024-03-11
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/26 Exercice

Chief Executive Officer

384,004 0.7713%
8/14/26 Exercice

Chief Financial Officer

56,214 0.1129%
8/14/26 Exercice

Executive/Senior Manager

16,554 0.0332%
Change 5-day change 1-year change 3-year change Capi.($)
+7.49%-1.49%-23.33%-50.16% 1.03B
+0.22%-1.29%-24.02%+3.92% 175B
+0.97%-3.79%-6.00%+10.84% 113B
-0.95%-0.60%+2.71%+63.94% 58.57B
+2.56%+1.59%+1.79%-31.09% 50.07B
+1.49%+3.89%+13.73%+52.30% 49.92B
-0.97%-3.06%+26.82%+0.65% 32.69B
+0.12%+9.67% - - 30.44B
-0.85%+2.24%+45.57%-1.37% 26.07B
-1.58%+7.22%+21.72%-6.35% 23.55B
Average +0.85%+1.40%+6.55%+4.74% 56.1B
Weighted average by Cap. +0.38%-0.01%-2.65%+12.25%

Financials

2026 *2027 *
Net sales 335M 294M 277M 253M 473M 32.07B 476M 3.32B 1.29B 16.38B 1.26B 1.23B 52.65B 361M 316M 299M 272M 510M 34.56B 513M 3.58B 1.38B 17.65B 1.35B 1.32B 56.74B
Net income 14.52M 12.74M 12.03M 10.97M 20.53M 1.39B 20.68M 144M 55.77M 711M 54.52M 53.34M 2.29B 28.13M 24.68M 23.31M 21.24M 39.77M 2.7B 40.05M 279M 108M 1.38B 106M 103M 4.43B
Net Debt -195M -171M -162M -147M -276M -18.71B -278M -1.94B -750M -9.56B -733M -717M -30.71B -241M -211M -200M -182M -340M -23.08B -343M -2.39B -925M -11.79B -904M -885M -37.89B
Logo STAAR Surgical Company
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also markets and sells an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company's principal products are ICLs used in refractive surgery, including its EVO family of lenses.
Employees
921
Date Price Change Volume
26-09-25 US$20.51 +7.49% 1,309,282
26-09-24 US$19.08 -3.64% 880,094
26-09-23 US$19.80 -4.12% 846,688
26-09-22 US$20.65 +1.62% 751,164
26-09-21 US$20.32 -2.40% 768,555
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
20.51USD
Average target price
27.40USD
Spread / Average Target
+33.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STAA Stock